Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them

Background and objective Adenocarcinoma is the most common type of lung cancer. It has been clinically evaluated that therapiestargeting against the epidermal growth factor receptor (EGFR) as the clinical standard first-line treatment. The response and outcome of EGFR-tyrosine kinase inhibitors (TKI...

Full description

Bibliographic Details
Main Authors: Yunshu SHI, Panhua LI, Banban LI, Fengming ZHANG, Siyuan HUANG, Shujing SHEN, Xingya LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EGFR
Mutation
Target therapy
EGFR-TKIs
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.06

Similar Items